Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-02-01
2011-02-01
Andres, Janet L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S300000, C546S152000, C546S156000
Reexamination Certificate
active
07879878
ABSTRACT:
A platelet aggregation inhibitor comprising a quinolone derivative or a pharmaceutically acceptable salt thereof as an active ingredient, and a novel quinolone derivative or a pharmaceutically acceptable salt thereof useful as a platelet aggregation inhibitor.
REFERENCES:
patent: 3943141 (1976-03-01), Ellis et al.
patent: 4024255 (1977-05-01), Ellis et al.
patent: 5024998 (1991-06-01), Bodor
patent: 5106837 (1992-04-01), Carson et al.
patent: 5324718 (1994-06-01), Loftsson
patent: 5506214 (1996-04-01), Beutler
patent: 5648368 (1997-07-01), Egbertson et al.
patent: 5753666 (1998-05-01), Beasley et al.
patent: 5889009 (1999-03-01), Miyake et al.
patent: 6121287 (2000-09-01), Bjork et al.
patent: 6130231 (2000-10-01), Wityak et al.
patent: 6136823 (2000-10-01), Sakae et al.
patent: 6248739 (2001-06-01), Turner et al.
patent: 6358976 (2002-03-01), Wityak et al.
patent: 6458788 (2002-10-01), Vaillancourt et al.
patent: 6875869 (2005-04-01), Jansson
patent: 7488739 (2009-02-01), Watanuki et al.
patent: 2002/0025961 (2002-02-01), Scarborough et al.
patent: 2002/0077486 (2002-06-01), Scarborough et al.
patent: 2002/0132806 (2002-09-01), Ruggeri et al.
patent: 2003/0060474 (2003-03-01), Bryant et al.
patent: 2003/0144305 (2003-07-01), Hardern et al.
patent: 2003/0153556 (2003-08-01), Levy et al.
patent: 2003/0162774 (2003-08-01), Scarborough et al.
patent: 2004/0147576 (2004-07-01), Scarborough et al.
patent: 2004/0186131 (2004-09-01), Wathen et al.
patent: 0945435 (1999-09-01), None
patent: 1433774 (1976-04-01), None
patent: 2372986 (2002-09-01), None
patent: 50-29574 (1975-03-01), None
patent: 50-35191 (1975-04-01), None
patent: 2001-139555 (2001-05-01), None
patent: 2002-531567 (2002-09-01), None
patent: 97/04779 (1997-02-01), None
patent: 98/23592 (1998-06-01), None
patent: 99/32450 (1999-07-01), None
patent: 00/34283 (2000-06-01), None
patent: 00/40561 (2000-07-01), None
patent: 00/40563 (2000-07-01), None
patent: 01/25239 (2001-04-01), None
patent: 01/57037 (2001-08-01), None
patent: 02/06513 (2002-01-01), None
patent: 02/070487 (2002-09-01), None
patent: 02/092571 (2002-11-01), None
patent: 02/098856 (2002-12-01), None
patent: 03/022214 (2003-03-01), None
patent: 2004/019932 (2004-03-01), None
International Search Report dated Oct. 26, 2004, in PCT/JP2004/010781.
Database Chemcats on STN, Accession No. 2003:2205826, Registry No. 375351-23-8 (2003), p. 1.
Database Chemcats on STN-Accession No. 2002:163154, Registry No. 375351-23-8 (2002), p. 1.
Nancee L. Oien et al., “Broad-Spectrum Antiherpes Activities of 4-Hydroxyquinoline Carboxamides, a Novel Class of Herpesvirus Polymerase Inhibitors”, Antimicrobial Agents and Chemotherapy, 2002, 46(3): 724-730.
C. Lossasso et al., “Effects of Lomefloxacin and Sparfloxacin on Human Platelet Aggregation”, Journal of Chemotherapy, 1995, 7(5):420-423.
European Office Action issued in Application No. 04 748 045.4—1216, dated Oct. 12, 2009.
Mexican Office Action dated Sep. 11, 2009.
Hirayama Fukushi
Kaga Daisuke
Koga Yuji
Moritani Yumiko
Moritomo Hiroyuki
Andres Janet L
Astellas Pharma Inc.
Gallis David E.
Sughrue & Mion, PLLC
LandOfFree
Quinolone derivative or salt thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolone derivative or salt thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolone derivative or salt thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2645682